Literature DB >> 26550364

Therapeutic effects and complications of simplified pericardial devascularization for patients with portal hypertension.

Hongwei Lu1, Sida Liu1, Yafei Zhang1, Hao Shang1, Hong Ji1, Yiming Li1.   

Abstract

OBJECTIVES: To evaluate the therapeutic effects and complications of simplified pericardial devascularization for patients with portal hypertension.
METHODS: By means of prospective study, 212 patients who underwent simplified pericardial devascularization (Group A) and 309 patients who underwent traditional pericardial devascularization (Group B) were followed up from 2003' to 2011'. Results were performed with the general condition of the patients and the incidence of complications to assess the value of the two operating methods.
RESULTS: The operating time was 1.0-3.83 hours (mean 1.94 ± 0.32 hours) in Group A versus 1.67-4.50 hours (mean 2.86 ± 0.40 hours) in Group B. The amount of bleeding, postoperative hospital stay and hospitalization expenses were 110-500 ml (mean 224.81 ± 78.44 ml), 7-22 days (mean 10.41 ± 4.01 days) and 15700-27500 yuan with an average of 19300 ± 1600 yuan in Group A and 200-700 ml (mean 423.50 ± 85.19 ml), 9-32 days (mean 14.76 ± 4.52 days) and 18700-44500 yuan with an average of 23400 ± 2200 yuan in Group B. In September 2012', successful follow-up was completed for 438 patients, of which, 181 underwent the simplified devascularization with 31 patients lost (follow-up rate 85.4%). Meanwhile, 257 patients in Group B were followed up completely and 52 patients were lost (follow-up rate 83.2%). The follow-up time ranged from 1 to 9.5 years and the average time was 5.03 ± 2.13 years. The mortality, rebleeding rate, rate of hepatic encephalopathy, rate of ascites and the incidence of gastric fistula and (or) esophageal fistula were 6.1%, 6.1%, 1.7%, 8.3% and 0 in Group A versus 14.0%, 15.2%, 4.3%, 17.7% and 3.1% in Group B.
CONCLUSIONS: The final results suggested that simplified pericardial devascularization performed more effectively and conveniently than the traditional method, depending on the mitigated operative wound and the shortened operation time. We concluded that simplified pericardial devascularization was better in treatment of portal hypertension compared than the traditional method.

Entities:  

Keywords:  Pericardial devascularization; operation effect; portal hypertension; postoperative complications; postoperative follow-up

Year:  2015        PMID: 26550364      PMCID: PMC4613049     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  13 in total

1.  Results of surgical treatment of uncontrollable upper gastrointestinal hemorrhage using endoscopy.

Authors:  Tsy Yeng Choy; Christian Simoens; Viviane Thill; Freddy Mboti; Shiran Vandaele; Pierre Mendes da Costa
Journal:  Hepatogastroenterology       Date:  2011 Jan-Feb

2.  Effects of modified splenocaval shunt plus devascularization on esophagogastric variceal bleeding: a comparative study of this treatment and devascularization only in cirrhotic portal hypertension.

Authors:  Lixue Du; Wujun Wu; Yu Zhang; Zhongjie Sun; Haitian Hu; Xiaogang Liu; Qingguang Liu
Journal:  J Hepatobiliary Pancreat Sci       Date:  2010-03-02       Impact factor: 7.027

3.  [Effects of medicine in prevention and treatment of upper gastrointestinal hemorrhage in portal hypertension].

Authors:  Wei-Min Wang; Xin-Guang Wang
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2007-07-01

Review 4.  [Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].

Authors:  Moon Young Kim; Soon Koo Baik
Journal:  Korean J Gastroenterol       Date:  2009-09

Review 5.  Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Richard Parker
Journal:  Clin Liver Dis       Date:  2014-05       Impact factor: 6.126

6.  Randomized clinical trial of vessel sealing system (LigaSure) in esophagogastric devascularization and splenectomy in patients with portal hypertension.

Authors:  Hou Shan Yao; Wei Jun Wang; Qiang Wang; Wen Chao Gao; Hong Gang Xiang; Zhi Qian Hu; Jia Dong Gao; Xue Yun Chen; Wei Min Wang
Journal:  Am J Surg       Date:  2011-07       Impact factor: 2.565

7.  [Evaluation of the pericardial devascularization in portal hypertension].

Authors:  F Z Qiu
Journal:  Zhonghua Wai Ke Za Zhi       Date:  1983-05

8.  Molecular pathophysiology of portal hypertension.

Authors:  Mercedes Fernandez
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

9.  Surgical and endovascular treatment of severe complications secondary to noncirrhotic portal hypertension: experience of 56 cases.

Authors:  Jidong Wu; Zhen Li; Zhonggao Wang; Xinwei Han; Feng Ji; Wayne W Zhang
Journal:  Ann Vasc Surg       Date:  2013-03-07       Impact factor: 1.466

10.  Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).

Authors:  Markus Peck-Radosavljevic; Bernhard Angermayr; Christian Datz; Arnulf Ferlitsch; Monika Ferlitsch; Valentin Fuhrmann; Michael Häfner; Ludwig Kramer; Andreas Maieron; Berit Payer; Thomas Reiberger; Rudolf Stauber; Rudolf Steininger; Michael Trauner; Siegfried Thurnher; Gregor Ulbrich; Wolfgang Vogel; Heinz Zoller; Ivo Graziadei
Journal:  Wien Klin Wochenschr       Date:  2013-04-12       Impact factor: 1.704

View more
  3 in total

1.  Comparison of simplified and traditional pericardial devascularisation combined with splenectomy for the treatment of portal hypertension.

Authors:  Ya-Fei Zhang; Hong Ji; Hong-Wei Lu; Le Lu; Lei Wang; Jin-Long Wang; Yi-Ming Li
Journal:  World J Clin Cases       Date:  2018-06-16       Impact factor: 1.337

2.  Risk Factors of Portal Vein Thrombosis after Devascularization Treatment in Patients with Liver Cirrhosis: A Nested Case-Control Study.

Authors:  Shenxin Lu; Guohua Hu; Shiyao Chen; Jian Wang
Journal:  Biomed Res Int       Date:  2020-08-27       Impact factor: 3.411

3.  Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension.

Authors:  Ya-Fei Zhang; Hong Ji; Hong-Wei Lu; Le Lu; Lei Wang; Jin-Long Wang; Yi-Ming Li
Journal:  World J Gastroenterol       Date:  2018-10-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.